We are live on ! Find out more
DC

Diametric Capital Portfolio holdings

AUM $385M
1-Year Est. Return 31.69%
This Fund
S&P 500
This Quarter Est. Return
-1.96%
1 Year Est. Return
+31.69%
3 Year Est. Return
+134.95%
5 Year Est. Return
+239.28%
10 Year Est. Return
AUM
$385M
AUM Growth
+$11.7M
Cap. Flow
+$39.6M
Cap. Flow %
10.28%
Top 10 Hldgs %
20.37%
Holding
618
New
251
Increased
83
Reduced
136
Closed
145

Sector Composition

Rank Sector Weight
1 Healthcare 23.21%
2 Consumer Discretionary 14.9%
3 Technology 14.08%
4 Industrials 11.68%
5 Financials 10.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGN
351
Legence Corp
LGN
$5.6B
$273K 0.07%
4,840
-34,300
-88% -$1.73M
TTEK icon
352
Tetra Tech
TTEK
$8.04B
$272K 0.07%
9,025
-9,045
-50% -$320K
CTMX icon
353
CytomX Therapeutics
CTMX
$725M
$270K 0.07%
+57,475
New +$292K
PLX icon
354
Protalix BioTherapeutics
PLX
$191M
$270K 0.07%
124,195
-14,734
-11% -$36.6K
MDLN
355
Medline Inc
MDLN
$31.4B
$269K 0.07%
6,041
-889
-13% -$39.3K
ONDS icon
356
Ondas Inc
ONDS
$4.56B
$268K 0.07%
+29,660
New +$323K
YTRA icon
357
Yatra Online
YTRA
$54.7M
$268K 0.07%
241,119
+38
+0% +$53
NABL icon
358
N-able
NABL
$804M
$268K 0.07%
57,285
+10,536
+23% +$58.9K
RAC
359
Rithm Acquisition Corp
RAC
$308M
$255K 0.07%
24,483
-429
-2% -$4.46K
FINV
360
FinVolution Group
FINV
$1.13B
$251K 0.07%
+52,449
New +$278K
VIOT
361
Viomi Technology
VIOT
$51.9M
$249K 0.06%
+224,543
New +$312K
AUTL
362
Autolus Therapeutics
AUTL
$383M
$247K 0.06%
178,731
-21,191
-11% -$32.2K
LTH icon
363
Life Time Group Holdings
LTH
$9.36B
$244K 0.06%
9,051
-15,167
-63% -$419K
TBBB icon
364
BBB Foods
TBBB
$4.87B
$243K 0.06%
+6,861
New +$240K
FRSH icon
365
Freshworks
FRSH
$2.78B
$240K 0.06%
+29,925
New +$276K
MYRG icon
366
MYR Group
MYRG
$6.37B
$238K 0.06%
+843
New +$219K
ANIK icon
367
Anika Therapeutics
ANIK
$200M
$238K 0.06%
16,413
-9,188
-36% -$107K
LNSR icon
368
LENSAR
LNSR
$70.6M
$236K 0.06%
39,573
+14,573
+58% +$158K
OMCL icon
369
Omnicell
OMCL
$1.86B
$235K 0.06%
+7,043
New +$295K
RNAC icon
370
Cartesian Therapeutics
RNAC
$239M
$234K 0.06%
+38,069
New +$271K
BIVIW
371
BioVie Inc Warrant
BIVIW
$160K
$233K 0.06%
750,000
ANRO icon
372
Alto Neuroscience
ANRO
$1.06B
$232K 0.06%
+10,315
New +$191K
NVT icon
373
nVent Electric
NVT
$25.6B
$223K 0.06%
1,884
-6,016
-76% -$683K
APA icon
374
APA Corp
APA
$12.8B
$222K 0.06%
+5,241
New +$158K
AGPU
375
Axe Compute Inc
AGPU
$80.9M
$222K 0.06%
+136,918
New +$447K

Similar funds

Diametric Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Diametric Capital held 618 positions worth $385M, up 3.1% from $373M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Diametric Capital deployed $39.6M of net new capital in Q1 2026, opening 251 new positions and adding to 83 existing holdings. Its largest new stake was Forgent Power Solutions: 144,593 shares worth $4.23M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Harrow, an estimated $7.36M trimmed.

  • Diametric Capital's largest Q1 2026 buy was Forgent Power Solutions: 144,593 shares worth $4.23M.
  • Diametric Capital added most to Precigen in Q1 2026, an estimated $12.1M increase.
  • Diametric Capital's biggest Q1 2026 reduction was Harrow, cutting an estimated $7.36M.
  • Diametric Capital fully exited Red Rock Resorts in Q1 2026, selling an estimated $5.36M.
  • Diametric Capital's ten largest holdings make up 20% of its $385M portfolio in Q1 2026.
  • Diametric Capital opened 251 new positions and closed 145 in Q1 2026.
  • Diametric Capital's portfolio value rose 3.1% quarter-over-quarter to $385M.

Based on Diametric Capital's 13F filing for Q1 2026, filed 15 May 2026.